Volume 29, Issue 163, September 2025

Assessment of quality of life in opinion of patients suffering from multiple sclerosis

Patrycja Patronik^1♦, Izabella Prządo¹, Łukasz Karaś¹, Sabina Krupa-Nurcek²

¹Medical College of the University of Rzeszów, Faculty of Medicine, Poland
²Collegium Medicum of the University of Rzeszów, Department of Surgery, Poland

^♦Corresponding author
Patrycja Patronik, Postal address: St. Hetmańska 75/85, Rzeszów, 36-078, Poland

ABSTRACT

Background: Multiple sclerosis is a disease characterized by multifocal damage to the central nervous system. The incurable and progressive nature of this disease significantly affects the quality of life of patients, covering both physical, mental, and social spheres of life. Aim of the study: Quality of life in the opinion of patients who have multiple sclerosis. Material and methods: A total of 107 individuals participated in an online survey aimed at assessing their quality of life. A diagnostic study design was employed, using the questionnaire as the primary research tool. The analysis focused on aspects such as disease duration, relapse frequency, presence of comorbidities, and the level of support received from family and community. Results: The study allowed us to conclude that the general assessment of the quality of life in the studied group of patients reached a medium level. Factors such as the duration of the disease, the form of multiple sclerosis, and the frequency of relapses had a significant impact on the assessment of the patients' quality of life. Respondents with a longer course of the disease and a higher incidence of relapses declared a lower quality of life. Conclusions: Increasing access to interdisciplinary care for a group of patients with multiple sclerosis is crucial. Respondents emphasize the need for better psychological and physiotherapeutic support. Furthermore, there is a need for additional research to develop methods that enhance the quality of life for patients with multiple sclerosis.

Keywords: quality of life; multiple sclerosis; demyelinating disease; patients

Medical Science, 2025, 29, e167ms3650

PDF

DOI: https://doi.org/10.54905/disssi.v29i163.e167ms3650

Published: 16 September 2025